Citation Impact
Citing Papers
Does the Evidence Support the Use of Mycophenolate Mofetil Therapeutic Drug Monitoring in Clinical Practice? A Systematic Review
2008
Elective cyclosporine withdrawal after renal transplantation. A meta-analysis.
1993
Effect of prolonged delayed graft function on long‐term graft outcome in cadaveric kidney transplantation
1994
A BLINDED, LONG-TERM, RANDOMIZED MULTICENTER STUDY OF MYCOPHENOLATE MOFETIL IN CADAVERIC RENAL TRANSPLANTATION
1998
Rethinking Chronic Allograft Nephropathy
1999
A RANDOMIZED MULTICENTER TRIAL OF THE ANTI-ICAM-1 MONOCLONAL ANTIBODY (ENLIMOMAB) FOR THE PREVENTION OF ACUTE REJECTION AND DELAYED ONSET OF GRAFT FUNCTION IN CADAVERIC RENAL TRANSPLANTATION
1999
Chronic Allograft Rejection
1993
The glutathione peroxidases
2001 Standout
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II
2010
Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial
2004
A Meta-Analysis of Immunosuppression Withdrawal Trials in Renal Transplantation
2000
Delayed graft function in kidney transplantation
2004 Standout
Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo
1996
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
2000 Standout
Glutathione peroxidases
2012 Standout
Messenger RNA for FOXP3 in the Urine of Renal-Allograft Recipients
2005
No Difference in Degree of Interstitial Sirius Red–Stained Area in Serial Biopsies from Area under Concentration-over-Time Curves–Guided Cyclosporine versus Tacrolimus-Treated Renal Transplant Recipients at One Year
2005
Noninvasive Diagnosis of Renal-Allograft Rejection by Measurement of Messenger RNA for Perforin and Granzyme B in Urine
2001
Post-transplant renal function in the first year predicts long-term kidney transplant survival
2002 Standout
The Role of Therapeutic Drug Monitoring in Individualizing Immunosuppressive Drug Therapy: Recent Developments
2006
PREDICTORS OF RENAL TRANSPLANT HISTOLOGY AT THREE MONTHS
1999
THE INDUCTION OF CLASS I AND II MAJOR HISTOCOMPATIBILITY COMPLEX BY ALLOGENEIC STIMULATION IS DEPENDENT ON THE TRANSCRIPTION FACTOR INTERFERON REGULATORY FACTOR 1 (IRF-1)
1996
Ultrasensitive Antibody Detection by Agglutination-PCR (ADAP)
2016 StandoutNobel
The Impact of Cytomegalovirus Infection and Disease on Rejection Episodes in Renal Allograft Recipients
2002
The Influence of Pharmacogenetics on the Time to Achieve Target Tacrolimus Concentrations after Kidney Transplantation
2004
Posttransplantation acute tubular necrosis: Risk factors and implications for graft survival
1998
Chronic Rejection in Kidney Transplants
1999
Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation
1999
Individualized Mycophenolate Mofetil Dosing Based on Drug Exposure Significantly Improves Patient Outcomes After Renal Transplantation
2007
Bioactive Natural Constituents from Food Sources—Potential Use in Hypertension Prevention and Treatment
2013
In vivo evaluation of the novel calcineurin inhibitor ISATX247 in Non-Human primates
2003
Renal-Cell Carcinoma
1996 Standout
Prevalence and Management of Anemia in Renal Transplant Recipients: A European Survey
2003
The relative influence of delayed graft function and acute rejection on renal transplant survival
1996
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Aciclovir
1994
A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTS
2001
Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients
2002 Standout
Expression of an antibody Fv fragment in myeloma cells
1988 StandoutNobel
Impact of cyclosporine withdrawal on living related renal transplants: A single-center experience
2001
SDZ RAD, A NEW RAPAMYCIN DERIVATIVE
1997 Standout
Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and p-glycoprotein correlate with dose requirement
2002
Early graft function and patient survival following cadaveric renal transplantation
1999
Pre-emptive Treatment for Cytomegalovirus Viremia to Prevent Cytomegalovirus Disease in Solid Organ Transplant Recipients
2006
IDENTIFICATION OF PATIENTS AT HIGH RISK OF GRAFT LOSS BY PRE- AND POSTTRANSPLANT MONITORING OF ANTI-HLA CLASS I IgG ANTIBODIES BY ENZYME-LINKED IMMUNOSORBENT ASSAY
1997
The Natural History of Chronic Allograft Nephropathy
2003 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Urinary tract infections after renal transplantation
2002
Comparison of Sirolimus vs. Mycophenolate Mofetil on Surgical Complications and Wound Healing in Adult Kidney Transplantation
2003
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression
1996 StandoutNobel
Therapeutic Drug Monitoring of Mycophenolate Mofetil in Transplantation
2006
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I
2010
Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients1
2003
Long-Term Efficacy and Safety of Cyclosporine in Renal-Transplant Recipients
1994
Steroid Withdrawal in Renal Transplant Patients on Triple Therapy with a Calcineurin Inhibitor and Mycophenolate Mofetil: A Meta-analysis of Randomized, Controlled Trials
2004
Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation
2008 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine
2001
DNA methylation-based biomarkers and the epigenetic clock theory of ageing
2018 Standout
Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
2003 Standout
Molecular mechanisms of carbonic anhydrase IX‐mediated pH regulation under hypoxia
2008 StandoutNobel
The Effect of Cyclosporine on the Use of Hospital Resources for Kidney Transplantation
1989
A NOVEL APPROACH TO THE TREATMENT OF CHRONIC ALLOGRAFT NEPHROPATHY1
1997
Cyclosporine
1989 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Risk factors for hypertension 3 years after renal transplantation in children
2007
Infection in Solid-Organ Transplant Recipients
2007 Standout
Recombinant human erythropoietin corrects anaemia during the first weeks after renal transplantation: a randomized prospective study
1996
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Nanoparticle and targeted systems for cancer therapy
2004 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Immunotherapy in Elderly Transplant Recipients
2009
Review of the proliferation inhibitor everolimus
2002
REDUCTION OF ACUTE RENAL ALLOGRAFT REJECTION BY DACLIZUMAB1
1999
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients
1997
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996
2000 Standout
MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTS
1997
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Urinary tract infections following renal transplantation
1998
An analysis of predictors of long‐term cadaveric renal allograft survival
1995
Predictors of long‐term primary cadaveric renal transplant survival
1993
Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1
2001 Standout
Interferon-γ: an overview of signals, mechanisms and functions
2003 Standout
MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANTATION: 3-YEAR RESULTS FROM THE PLACEBO-CONTROLLED TRIAL1
1999
Delayed graft function
2001
The clinical and cost-effectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and non-heart-beating donors
2003
Penile Arteriography in Impotence After Pelvic Trauma
1981
CYCLOSPORIN CONVERSION VERSUS CONVENTIONAL IMMUNOSUPPRESSION: LONG-TERM FOLLOW-UP AND HISTOLOGICAL EVALUATION
1987
Infections in solid-organ transplant recipients
1997
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
2013
CLINICAL CORRELATES OF CHRONIC REJECTION IN PEDIATRIC RENAL TRANSPLANTATION
1996
Effect of anti-lymphocyte induction therapy on renal allograft survival
1997
Urinary tract infection in renal transplant patients
1985
Varicella-zoster virus
1996 Standout
Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice.
1986
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Human Anti-Animal Antibody Interferences in Immunological Assays
1999
The lens after renal transplantation.
1990 StandoutNobel
Evaluating non-randomised intervention studies
2003 Standout
Altered Patterns of Posttransplant Urinary Tract Infections Associated With Perioperative Antibiotics and Curtailed Catheterization
1985
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1
1996 Standout
Impotence Following Radical Prostatectomy: Insight Into Etiology and Prevention
1982 Standout
The relative influence of delayed graft function and acute rejection on renal transplant survival
1996
PROGNOSTIC INDICATORS FOR RENAL CELL CARCINOMA: A MULTIVARIATE ANALYSIS OF 643 PATIENTS USING THE REVISED 1997 TNM STAGING CRITERIA
2000
Aspergillus fumigatusand Aspergillosis
1999 Standout
Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients
1993
Delayed Graft Function in Renal Transplantation: Etiology, Management and Long-term Significance
1996
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
PROGNOSTIC FACTORS IN RENAL CANCER
1993
Early Cyclosporine C0 and C2 Monitoring in De Novo Kidney Transplant Patients: A Prospective Randomized Single-Center Pilot Study
2006
Delayed graft function. Influence on outcome and strategies for prevention.
2001
Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma
1999 Standout
The use of monoclonal antibody G250 in the therapy of renal-cell carcinoma.
1995
Human kidney proximal tubules are the main source of plasma glutathione peroxidase
1994
Tumor Size Predicts Synchronous Metastatic Renal Cell Carcinoma: Implications for Surveillance of Small Renal Masses
2007
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy
1998
The Effect of Antilymphocyte Induction Therapy on Renal Allograft Survival
1998
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000
The Continuing Challenges of Leprosy
2006 Standout
Hepatotoxicity Associated With Cyclosporine Monitoring Using C2 Recommendations in Adults Renal Recipients Receiving Ketoconazole
2005
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2013
Works of P Belitsky being referenced
A Randomized Double‐Blind Placebo Controlled Trial of Oral Acyclovir in Renal Allograft Recipients
1992
Analysis of imaging modalities, staging systems, and prognostic indicators for renal cell carcinoma
1992
Inhibition of human renal cancer by monoclonal-anti-body-linked methotrexate in an ascites tumor model
1991
Sensitivity of normal and neoplastic human renal tubular epithelium to hyperthermia
1988
Low-dose subcutaneous erythropoietin corrects the anaemia of renal transplant failure
1992
Neoral use in the renal transplant recipient
2000
Impact of Absorption Profiling on Efficacy and Safety of Cyclosporin Therapy in Transplant Recipients
2000
Alloimmune Thrombocytopenia after Organ Transplantation
1999
Effect of Calcium-Channel Blockers on Cyclosporine Clearance and Use in Renal Transplant Patients
1994
Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants
2000
Approaching the Therapeutic Window for Cyclosporine in Kidney Transplantation
2001
Early Adequate Mycophenolic Acid Exposure is Associated with Less Rejection in Kidney Transplantation
2004
REDUCTION BY COMBINATION PROPHYLACTIC THERAPY WITH CMV HYPERIMMUNE GLOBULIN AND ACYCLOVIR OF THE RISK OF PRIMARY CMV DISEASE IN RENAL TRANSPLANT RECIPIENTS
1993
Inhibition of human renal cancer by monoclonal antibody targeted methotrexate-containing liposomes in an ascites tumor model
1991
Adequate Early Cyclosporin Exposure is Critical to Prevent Renal Allograft Rejection: Patients Monitored by Absorption Profiling
2002
THE INCIDENCE AND IMPACT OF EARLY REJECTION EPISODES ON GRAFT OUTCOME IN RECIPIENTS OF FIRST CADAVER KIDNEY TRANSPLANTS
1992
INDUCTION OF MHC CLASS II EXPRESSION IN RECIPIENT TISSUES CAUSED BY ALLOGRAFT REJECTION
1990
Early prediction of renal allograft loss beyond one year
1993
Urinary tract infections (UTI) after kidney transplantation.
1982
Repeat Cadaver Kidney Transplantation Using Cyclosporine a Immunosuppression
1987
Recent advances in therapeutic monitoring of cyclosporine: Absorption profiling
2001
MDR1 C3435T Polymorphisms Correlate With Cyclosporine Levels in De Novo Renal Recipients
2006
Cyclosporin A and hypertension in pediatric renal transplant recipients.
1989
THE MORBIDITY OF PROLONGED WOUND DRAINAGE AFTER KIDNEY TRANSPLANTATION
1999
Cytomegalovirus disease prophylaxis in seronegative recipients of kidneys from seropositive donors by combination of cytomegalovirus-hyperimmune globulin and low-dose acyclovir.
1991
Conversion from cyclosporine to azathioprine in renal graft recipients.
1985
Use of rabbit anti-thymocyte globulin for induction immunosuppression in high-risk kidney transplant recipients
1997
Rupture of the Posterior Urethra
1972
Effect of immunosuppression on chronic rejection in the rat aortic allograft model.
1993
Early prediction of renal allograft loss beyond one year
1993
Randomized controlled trial of steroids versus no steroids in stable cyclosporine-treated renal graft recipients.
1991
Localization of 131I-labeled antibodies in human renal cell carcinomas and in a mouse hepatoma and correlation with tumor detection by photoscanning.
1980
ABSORPTION PROFILING - A NOVEL METHOD FOR MONITORING NEORAL IN KIDNEY TRANSPLANTATION THAT REDUCES REJECTION AND NEPHROTOXICITY.
2000
Long-term follow-up of cyclosporine-treated renal allograft recipients.
1988
Rational clinical regimens for kidney transplant immunosuppression.
1994
Monoclonal antibodies to kidney and tumor-associated surface antigens of human renal cell carcinoma.
1986
Comparison of antilymphocyte globulin and continuous i.v. cyclosporine A as induction immunosuppression for cadaver kidney transplants: a prospective randomized study.
1991
Progress in renal transplantation.
2000
Significance of delayed function in cyclosporine-treated cadaver kidney transplants.
1987
KIDNEY TRANSPLANTATION IN CHILDREN WITH URINARY DIVERSION OR BLADDER AUGMENTATION
2001